Acquired generalized lipodystrophy

From WikiMD.org
Jump to navigation Jump to search

Acquired Generalized Lipodystrophy (AGL), also known as Lawrence Syndrome, is a rare medical condition characterized by the widespread loss of adipose tissue, leading to a lack of insulin sensitivity and various metabolic complications.

Pronunciation

The term is pronounced as a-kwahyerd jen-uh-ruh-lahyzd lip-uh-dis-truh-fee.

Etymology

The term "Acquired Generalized Lipodystrophy" is derived from the following roots:

  • Acquired: Derived from the Latin word 'acquirere', meaning 'to obtain'.
  • Generalized: Derived from the Latin word 'generalis', meaning 'pertaining to all'.
  • Lipodystrophy: Derived from the Greek words 'lipos' (fat), 'dys' (abnormal), and 'trophe' (nourishment).

Definition

Acquired Generalized Lipodystrophy is a disorder characterized by the progressive loss of adipose tissue, predominantly from subcutaneous regions of the body. This condition is acquired, meaning it develops after birth, usually during childhood or adolescence.

Symptoms

The symptoms of Acquired Generalized Lipodystrophy include:

Diagnosis

Diagnosis of Acquired Generalized Lipodystrophy is based on clinical evaluation, detailed patient history, and specialized tests such as magnetic resonance imaging (MRI) or computed tomography (CT) scans to assess the distribution of body fat.

Treatment

Treatment for Acquired Generalized Lipodystrophy is primarily aimed at managing the metabolic complications associated with the condition. This may include insulin therapy, diet modification, and medications to control triglyceride levels.

Related Terms

External links

Esculaap.svg

This WikiMD article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski